LIFW vs. DCGO, CLOV, EOLS, RNA, WVE, MODV, RPTX, EXAI, THRN, and SVRA
Should you be buying MSP Recovery stock or one of its competitors? The main competitors of MSP Recovery include DocGo (DCGO), Clover Health Investments (CLOV), Evolus (EOLS), Avidity Biosciences (RNA), Wave Life Sciences (WVE), ModivCare (MODV), Repare Therapeutics (RPTX), Exscientia (EXAI), Thorne HealthTech (THRN), and Savara (SVRA). These companies are all part of the "medical" sector.
MSP Recovery vs.
MSP Recovery (NASDAQ:LIFW) and DocGo (NASDAQ:DCGO) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, analyst recommendations, risk, media sentiment, institutional ownership, dividends, valuation, earnings and community ranking.
DocGo has a consensus price target of $13.60, suggesting a potential upside of 166.67%. Given DocGo's higher possible upside, analysts clearly believe DocGo is more favorable than MSP Recovery.
MSP Recovery has a beta of -1.23, meaning that its stock price is 223% less volatile than the S&P 500. Comparatively, DocGo has a beta of 0.85, meaning that its stock price is 15% less volatile than the S&P 500.
6.2% of MSP Recovery shares are held by institutional investors. Comparatively, 52.1% of DocGo shares are held by institutional investors. 19.4% of MSP Recovery shares are held by insiders. Comparatively, 13.8% of DocGo shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
DocGo has higher revenue and earnings than MSP Recovery.
DocGo received 27 more outperform votes than MSP Recovery when rated by MarketBeat users.
DocGo has a net margin of 1.27% compared to MSP Recovery's net margin of -29.08%. DocGo's return on equity of 3.20% beat MSP Recovery's return on equity.
In the previous week, DocGo had 13 more articles in the media than MSP Recovery. MarketBeat recorded 17 mentions for DocGo and 4 mentions for MSP Recovery. MSP Recovery's average media sentiment score of 0.28 beat DocGo's score of 0.04 indicating that MSP Recovery is being referred to more favorably in the media.
Summary
DocGo beats MSP Recovery on 11 of the 14 factors compared between the two stocks.
Get MSP Recovery News Delivered to You Automatically
Sign up to receive the latest news and ratings for LIFW and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding LIFW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
MSP Recovery Competitors List
Related Companies and Tools